1. Dipòsit Digital de la Universitat de Barcelona
  2. Recerca
  3. Farmàcia, Tecnologia Farmacèutica i Fisicoquímica
  4. Articles publicats en revistes (Farmàcia, Tecnologia Farmacèutica i Fisicoquímica)
Please use this identifier to cite or link to this item: http://hdl.handle.net/2445/177455
Full metadata record
DC FieldValueLanguage
dc.contributor.authorGironés Petit, Robert-
dc.contributor.authorCano Fernández, Amanda-
dc.contributor.authorOrtiz Rodrigo, Alba-
dc.contributor.authorEspina García, Marta-
dc.contributor.authorPrat Aixelà, Josefa-
dc.contributor.authorMuñoz Juncosa, Montserrat-
dc.contributor.authorSeverino, Patrícia-
dc.contributor.authorSouto, Eliana B.-
dc.contributor.authorGarcía López, María Luisa-
dc.contributor.authorPujol Cubells, Montserrat-
dc.contributor.authorSánchez-López, E. (Elena)-
dc.date.accessioned2021-05-20T09:58:42Z-
dc.date.available2021-05-20T09:58:42Z-
dc.date.issued2021-05-07-
dc.identifier.issn1661-6596-
dc.identifier.urihttp://hdl.handle.net/2445/177455-
dc.description.abstractResearch in the pathogenesis of inflammatory skin diseases, such as skin dermatitis and psoriasis, has experienced some relevant breakthroughs in recent years. The understanding of age-related factors, gender, and genetic predisposition of these multifactorial diseases has been instrumental for the development of new pharmacological and technological treatment approaches. In this review, we discuss the molecular mechanisms behind the pathological features of psoriasis, also addressing the currently available treatments and novel therapies that are under clinical trials. Innovative therapies developed over the last 10 years have been researched. In this area, advantages of nanotechnological approaches to provide an effective drug concentration in the disease site are highlighted, together with microneedles as innovative candidates for drug delivery systems in psoriasis and other inflammatory chronic skin diseases. View Full-Text Keywords: skin inflammatory diseases; psoriasis; psoriasis versus atopic dermatitis; biodegradable nanoparticles; microneedles; clinical trials-
dc.format.mimetypeapplication/pdf-
dc.language.isoeng-
dc.publisherMDPI-
dc.relation.isformatofReproducció del document publicat a: https://doi.org/10.3390/ijms22094983-
dc.relation.ispartofInternational Journal of Molecular Sciences, 2021, vol. 22, num. 9, p. 4983-
dc.relation.urihttps://doi.org/10.3390/ijms22094983-
dc.rightscc-by (c) Gironés Petit, Robert et al., 2021-
dc.rights.urihttps://creativecommons.org/licenses/by/4.0/-
dc.sourceArticles publicats en revistes (Farmàcia, Tecnologia Farmacèutica i Fisicoquímica)-
dc.subject.classificationMalalties de la pell-
dc.subject.classificationPsoriasi-
dc.subject.classificationDermatitis-
dc.subject.otherSkin diseases-
dc.subject.otherPsoriasis-
dc.subject.otherDermatitis-
dc.titlePsoriasis: From Pathogenesis to Pharmacological and Nano-Technological-Based Therapeutics-
dc.typeinfo:eu-repo/semantics/article-
dc.typeinfo:eu-repo/semantics/publishedVersion-
dc.identifier.idgrec712199-
dc.date.updated2021-05-20T09:58:42Z-
dc.rights.accessRightsinfo:eu-repo/semantics/openAccess-
dc.identifier.pmid34067151-
Appears in Collections:Articles publicats en revistes (Farmàcia, Tecnologia Farmacèutica i Fisicoquímica)

Files in This Item:
File Description SizeFormat 
712199.pdf1.82 MBAdobe PDFView/Open
Show simple item record


This item is licensed under a Creative Commons License Creative Commons